Related references
Note: Only part of the references are listed.Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine
Song Guo et al.
CEPHALALGIA (2017)
Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients
Song Guo et al.
CEPHALALGIA (2017)
PACAP38 dose-response pilot study in migraine patients
Anne Luise Haulund Vollesen et al.
CEPHALALGIA (2017)
PACAP38: Emerging Drug Target in Migraine and Cluster Headache
Anne Luise Haulund Vollesen et al.
HEADACHE (2017)
Measurement of Blood Flow Velocity in the Middle Cerebral Artery During Spontaneous Migraine Attacks: A Systematic Review
Nisar A. Shayestagul et al.
HEADACHE (2017)
Triptans and CGRP blockade - impact on the cranial vasculature
Silvia Benemei et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Challenges in developing drugs for primary headaches
Henrik Winther Schytz et al.
PROGRESS IN NEUROBIOLOGY (2017)
Change in brain network connectivity during PACAP38-induced migraine attacks A resting-state functional MRI study
Faisal Mohammad Amin et al.
NEUROLOGY (2016)
The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks
Laura H. Schulte et al.
BRAIN (2016)
Release of PACAP-38 in episodic cluster headache patients - an exploratory study
Bernadett Tuka et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
Song Guo et al.
PAIN (2016)
Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine
Janos Tajti et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine
Simon Akerman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks
Farooq Husain Maniyar et al.
BRAIN (2014)
Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase
Song Guo et al.
BRAIN (2014)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Faisal Mohammad Amin et al.
BRAIN (2014)
PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: Possible involvement of mast cells
Deepak K. Bhatt et al.
CEPHALALGIA (2014)
Measurement precision and biological variation of cranial arteries using automated analysis of 3 T magnetic resonance angiography
Faisal Mohammad Amin et al.
JOURNAL OF HEADACHE AND PAIN (2014)
Pituitary adenylate cyclase activating polypeptide and migraine
Alessandro S. Zagami et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method
Gustaf Grande et al.
CEPHALALGIA (2013)
Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients
Bernadett Tuka et al.
CEPHALALGIA (2013)
The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers
Faisal Mohammad Amin et al.
CEPHALALGIA (2013)
Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
Sajedeh Eftekhari et al.
JOURNAL OF PAIN (2013)
The brain basis of emotion: A meta-analytic review
Kristen A. Lindquist et al.
BEHAVIORAL AND BRAIN SCIENCES (2012)
Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
Faisal Mohammad Amin et al.
CEPHALALGIA (2012)
Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38
Michael Baun et al.
CEPHALALGIA (2012)
Evidence for a Vascular Factor in Migraine
Mohammad S. Asghar et al.
ANNALS OF NEUROLOGY (2011)
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery
Kayi Y. Chan et al.
CEPHALALGIA (2011)
Increased limbic and brainstem activity during migraine attacks following olfactory stimulation
Anne Stankewitz et al.
NEUROLOGY (2011)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers
M. S. Asghar et al.
NEUROLOGY (2010)
The PACAP Receptor: A Novel Target for Migraine Treatment
Henrik W. Schytz et al.
NEUROTHERAPEUTICS (2010)
PACAP38 induces migraine-like attacks in patients with migraine without aura
Henrik Winther Schytz et al.
BRAIN (2009)
The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery
L. J. Boni et al.
CEPHALALGIA (2009)
VPAC and PAC receptors: From ligands to function
Louise Dickson et al.
PHARMACOLOGY & THERAPEUTICS (2009)
The brain's default network - Anatomy, function, and relevance to disease
Randy L. Buckner et al.
YEAR IN COGNITIVE NEUROSCIENCE 2008 (2008)
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine
A. Rahmann et al.
CEPHALALGIA (2008)
Neuropeptides activate human mast cell degranulation and chemokine production
Marianna Kulka et al.
IMMUNOLOGY (2008)
Novel stable PACAP analogs with potent activity towards the PAC1 receptor
Steve Bourgault et al.
PEPTIDES (2008)
Mast cell degranulation activates a pain pathway underlying migraine headache
Dan Levy et al.
PAIN (2007)
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers
Steffen Birk et al.
REGULATORY PEPTIDES (2007)
Dissociable intrinsic connectivity networks for salience processing and executive control
William W. Seeley et al.
JOURNAL OF NEUROSCIENCE (2007)
PACAP - A multifacetted neuropeptide
J Fahrenkrug
CHRONOBIOLOGY INTERNATIONAL (2006)
Glyceryl trinitrate triggers premonitory symptoms in migraineurs
SK Afridi et al.
PAIN (2004)
The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow
S Birk et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Passage of VIP/PACAP/secretin family across the blood-brain barrier: Therapeutic effects
D Dogrukol-Ak et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Distribution of PACAP-38 in the central nervous system of various species determined by a novel radioimmunoassay
B Jakab et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2004)
New directions in migraine research
PJ Goadsby
JOURNAL OF CLINICAL NEUROSCIENCE (2002)
Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia
M Knutsson et al.
NEUROREPORT (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2
R Uddman et al.
CEPHALALGIA (2002)
Cilostazol (Pletal®):: A dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake
YG Liu et al.
CARDIOVASCULAR DRUG REVIEWS (2001)
Plasma levels of calcitonin gene-related peptide in chronic tension-type headache
M Ashina et al.
NEUROLOGY (2000)
Functional imaging of brain responses to pain.: A review and meta-analysis (2000)
R Peyron et al.
NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY (2000)
Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels:: Relation to PACAP and VIP containing nerves
J Fahrenkrug et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Glyceryl trinitrate induced headache in migraineurs - relation to attack frequency
I Christiansen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2000)
Share Paper
